Rakesh Jain, MD

JCP
Dysregulation of Noradrenergic Activity
Academic Highlights

November 8, 2024

Dysregulation of noradrenergic activity plays a key role in symptom presentation in major depressive disorder, schizophrenia, Alzheimer’s agitation, and PTSD. This article provides an expert panel’s consensus regarding the...
, , , et al
JCP
Impact of Tardive Dyskinesia on Patient Lives
Original Research

April 3, 2023

This survey reveals the substantial burden of tardive dyskinesia on people’s lives and on the management of their underlying condition.
, , , et al
PCC
Original Research

September 17, 2020

Bipolar disorder is characterized by a chronic and subtle course of fluctuating symptoms. To explore the efficacy of cariprazine across the symptoms of bipolar depression, post hoc analyses of...
, , , et al
JCP
Consensus Statement

January 28, 2020

Tardive dyskinesia remains a serious complication associated with dopamine receptor blocking agents. In this article, read guidance from experts on best practices for tardive dyskinesia screening, diagnosis, and treatment.
, , , et al
JCP
Academic Highlights

March 20, 2018

Read a study where experts review the prevalence, phenomenology, risk factors, and impact of Tardive Dyskinesia (TD).
,
JCP
Educational Activity

January 9, 2018

Most patients with major depressive disorder will not achieve remission with initial treatment. Strategies to increase the likelihood of achieving remission include regularly measuring response, assessing adverse effects and...
JCP
Academic Highlights

September 26, 2017

Descriptions of mixed states can be found in the writings of ancient Greek physicians, and the concept continues to be refined. In this CME activity, join experts as they...
, ,
PCC
Article

September 7, 2017

ADHD was originally defined in children but is now recognized to persist into adulthood for some patients. Despite this recognition, adult ADHD remains underdiagnosed. This article describes the negative...
, ,
PCC
Article

August 18, 2016

With more than 20 different pharmacologic options for the treatment of ADHD, how do you know what will work best for your patients? Read this systematic review to find...
,
JCP
Educational Activity

February 24, 2016

, ,
JCP
Educational Activity

January 27, 2016

JCP
Educational Activity

December 23, 2015

, ,

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe